PACIRA BIOSCIENCES, INC.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $14.6M $15.0M
Cost of Revenue $12.3M $12.3M
Gross Profit $2.3M $2.7M
Gross Margin 15.7% 18.0%
Operating Expenses
Research & Development $18.6M $26.2M
SG&A Expense $6.4M $5.0M
Operating Income $-22.7M $-28.5M
Operating Margin -155.9% -190.2%
Interest Expense $4.0M $1.7M
Pretax Income
Income Tax Expense
Net Income $-27.1M $-31.7M
Net Margin -186.4% -211.3%
EPS (Basic) $-1.63 $-1.91
EPS (Diluted) $-1.63 $-1.91
Shares Outstanding (Basic) 16.6M 16.6M
Shares Outstanding (Diluted) 16.6M 16.6M
Dividends Per Share
← Newer Page 3 of 3 Older →